Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Marchand DH, Remmel RP, Abdel-Monem MM
Who Might Be a Good Candidate for Retatrutide Treatment
Groups More Likely to Experience Nausea Clinical data indicate that nausea is more common in: First-time PT-141 users Patients receiving higher initial doses Premenopausal women treated for hypoactive sexual desire disorder (HSDD) Those with prior medication sensitivity or a history of motion sickness Additional caution is warranted in patients with cardiovascular disease due to the medications potential effects on blood pressure
In the phase 3 ADAPT trial, its use compared to placebo attained clinically meaningful improvements in the MG-ADL [45]
US$ 20.88
US$ 22.34
US$ 23.72
US$ 26.16
US$ 20.62
US$ 28.66
US$ 28.63
